SCHEMBL5160111

SCHEMBL5160111

O=c1[nH]nc(CNc2ccc(Cl)cc2)c2ccccc12

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.75
▸ KMT2A Q03164 4/20 0.75
▸ HTT P42858 3/20 0.75
▸ GAA P10253 2/20 0.75
▸ KDM4E B2RXH2 2/20 0.75
▸ MEN1 O00255 2/20 0.75
▸ ALDH1A1 P00352 2/20 0.75
▸ THRB P10828 1/20 0.75
▸ RECQL P46063 1/20 0.75
▸ BLM P54132 1/20 0.75
▸ LMNA P02545 4/20 0.68
▸ SMN1; SMN2 Q16637 3/20 0.65
▸ TDP1 Q9NUW8 1/20 0.59
▸ HIF1A Q16665 1/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.54
▸ BRD4 O60885 1/20 0.54
▸ PRMT5 O14744 1/20 0.53
▸ AR P10275 4/20 0.52
▸ RXFP1 Q9HBX9 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5165966 0.88 MAPT (0.78) MAPTKMT2AHTTGAAKDM4E
SCHEMBL5160240 0.86 MAPT (1.00) MAPTKMT2AHTTGAAKDM4E
SCHEMBL5164835 0.82 MAPT (0.77) MAPTKMT2AHTTGAAKDM4E
SCHEMBL5161752 0.82 MAPT (1.00) MAPTKMT2AHTTGAAKDM4E
SCHEMBL23657600 0.81 LMNA (1.00) MAPTKMT2AHTTGAAKDM4E
SCHEMBL5162135 0.81 MAPT (0.68) MAPTKMT2AHTTGAAKDM4E
SCHEMBL5165083 0.79 HTT (1.00) MAPTKMT2AHTTGAAKDM4E
SCHEMBL6281157 0.78 MAPT (0.64) MAPTKMT2AHTTGAAKDM4E
SCHEMBL1789242 0.78 LMNA (1.00) KMT2AHTTKDM4EMEN1ALDH1A1
SCHEMBL29349943 0.78 LMNA (1.00) KMT2AHTTKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1231982-B1 USE OF PHTHALAZINE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES ABBOTT GMBH & CO KG (DE) 2007-03-21 — — EP disclosed
US-6903098-B1 Use of phthalazine derivatives ABBOTT GMBH & CO. (DE) 2005-06-07 — — US disclosed
Send feedback